Evaluation of short-and long-term response to treatment in GIMEMA protocol for acute myeloid leukaemia

I. Ardoino, F. Ambrogi, S. Iacobelli, P. Boracchi, G. Manikis, M. G. Kounelakis, M. Zervakis, P. J G Lisboa, P. Fazi, M. Vignetti, E. M. Biganzoli, A. Starita

Research output: Contribution to journalArticle

Abstract

Acute Myeloid Leukaemia (AML) is a haematologic malignancy. Despite of improvements in prognosis it is still a severe disease and only a minority of patients are cured. Recently, insights into specific cytogenetics and biological aberration involved in the leukaemogenesis process are the target of research. LAM-99P GIMEMA Protocol identifies treatment guidelines for AML in adults. A methodological approach is proposed, compounding different modelling techniques, to assess the prognostic relevance of clinical as well as biological markers with regard to clinical endpoint, such as the achievement of Complete Remission in the short-term and long-term survival taking into account competing risks.

Original languageEnglish
Pages (from-to)329-348
Number of pages20
JournalInternational Journal of Biomedical Engineering and Technology
Volume3
Issue number3-4
DOIs
Publication statusPublished - Apr 2010

Keywords

  • Acute myeloid leukaemia
  • AML
  • Competing risks
  • CR
  • Multinomial logistic regression
  • Support vector machines
  • Survival analysis

ASJC Scopus subject areas

  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Evaluation of short-and long-term response to treatment in GIMEMA protocol for acute myeloid leukaemia'. Together they form a unique fingerprint.

  • Cite this

    Ardoino, I., Ambrogi, F., Iacobelli, S., Boracchi, P., Manikis, G., Kounelakis, M. G., Zervakis, M., Lisboa, P. J. G., Fazi, P., Vignetti, M., Biganzoli, E. M., & Starita, A. (2010). Evaluation of short-and long-term response to treatment in GIMEMA protocol for acute myeloid leukaemia. International Journal of Biomedical Engineering and Technology, 3(3-4), 329-348. https://doi.org/10.1504/IJBET.2010.032699